PegIntron Versus Adefovir in the Treatment of Chronic Hepatitis B (CHB) e Antigen Positive Patients in Taiwan (P04498/MK-4031-278)

NCT00371761 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

25

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatitis B, Chronic (CHB)

Interventions

BIOLOGICAL: Pegylated interferon alfa-2b (PegIntron)
DRUG: Adefovir dipivoxil (adefovir)

Sponsor

Merck Sharp & Dohme LLC